Two studies have found that human plasma albumin (HSA) significantly reduces α-syn aggregation and fibrillation, and it has even been proposed that HSA has a chaperonin-like ability to resist amyloid aggregation, which is the key to AD pathology (Kakinen et al., 1860; Bellomo et al., 2019). Here, ALB is linked to Alzheimer disease.